Crystal Structure
Crystallisation Method: EM
Corresponding Chain: B/D
Sequence Length: 2-487
Detail: Struture Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0476 | ||||
Gene Name | SLC7A9 | ||||
Protein Name | Glycoprotein-associated amino acid transporter b0, +AT1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Crystal Structure Crystallisation Method: EM Corresponding Chain: B/D Sequence Length: 2-487 Detail: Struture Info |
||||
Synonyms | BAT1; CSNU3; SLC7A9; Solute carrier family 7 member 9; b(0,+)-type amino acid transporter 1; b(0,+)AT1 | ||||
DT Family | Amino Acid-Polyamine-Organocation (APC) Family | ||||
L-type Amino Acid Transporter (LAT) Family | |||||
Tissue Specificity | Expressed in the brush border membrane in thekidney (at protein level). Kidney, small intestine, liver andplacenta. | ||||
Function | This transporter thought to be responsible for the high-affinity reabsorption of cystine in the kidney tubule. Involved in the high-affinity, sodium-independent transport of cystine and neutral and dibasic amino acids (system b(0,+)-like activity). | ||||
Endogenous Substrate(s) | Cystine; Neutral and dibasic amino acids | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
L-citrulline
|
Phase 3 | Drug Info | Congenital heart defects | LA8Z | [1] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Cystine | EM Info | Identified using Slc7a9 knockout mice | [2] | ||
References | |||||
1 | Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells. Biopharm Drug Dispos. 2009 Apr;30(3):126-37. | ||||
2 | Differential cystine and dibasic amino acid handling after loss of function of the amino acid transporter b0,+AT (Slc7a9) in mice. Am J Physiol Renal Physiol. 2013 Dec 15;305(12):F1645-55. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.